Tip 4: Inhibition of the vascular endothelial growth factor pathway by VEGF inhibitors and tyrosine kinase inhibitors leads to a spectrum of complications from hypertension to renal thrombotic microangiopathy. Here, VEGFA is linked to hypertensive disorder.